Prosecution Insights
Last updated: August 18, 2026

Examiner: FRITCHMAN, REBECCA M

Tech Center 1700 • Art Units: 1652 1758 1759 1767 1777 1796 1797

This examiner grants 46% of resolved cases

Performance Statistics

45.7%
Allow Rate
-19.3% vs TC avg
748
Total Applications
+35.8%
Interview Lift
1469
Avg Prosecution Days
Based on 661 resolved cases, 2023–2026

Rejection Statute Breakdown

5.0%
§101 Eligibility
9.1%
§102 Novelty
59.5%
§103 Obviousness
20.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18147094 USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN Non-Final OA Abbott Laboratories
17423868 Urine metabolomics based method of detecting renal allograft injury Non-Final OA The Regents of the University of California
17787015 ENDOTOXIN DETECTION Final Rejection Eli Lilly and Company
18606302 Proteomic Risk Score For Osteoarthritis (OA) Non-Final OA Regeneron Pharmaceuticals, Inc.
18221934 ISOELECTRIC FOCUSING-BASED ENRICHMENT OF CHARGE VARIANT SPECIES Non-Final OA Regeneron Pharmaceuticals, Inc.
17880676 TARGET MATERIAL IDENTIFICATION METHOD Final Rejection Taiwan Semiconductor Manufacturing Company, Ltd.
18696187 METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRIGONELLINE AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
17633917 BIOMARKERS FOR NEURODEGENERATIVE DISORDERS Non-Final OA The Johns Hopkins University
18579811 METHODS OF DETECTING PENTASACCHARIDES AND TREATMENT AND MONITORING OF LYSOSOMAL STORAGE DISEASE Non-Final OA Washington University
18027393 CONTINUOUS OPTICAL APTAMER SENSORS Final Rejection University Of Cincinnati
18306195 DETECTION OF AN ANALYTE OF INTEREST BY NANOESI MASS SPECTROMETRY Non-Final OA Roche Diagnostics Operations, Inc.
18028235 CIRCULATING TOTAL-NT-PROBNP (GLYCOSYLATED AND UNGLYCOSYLATED NT-PROBNP) AND ITS RATIO WITH NT-PROBNP (UNGLYCOSYLATED NT-PROBNP) IN THE ASSESSMENT OF ATRIAL FIBRILLATION Final Rejection Roche Diagnostics Operations, Inc.
18044752 DIAGNOSTIC METHODS FOR KAWASAKI DISEASE Final Rejection SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
18289130 OPTICAL EMISSION BIOSENSING USING MAGNETIC BEADS WITH A FAST AGGREGATION TIME Non-Final OA Bar-Ilan University
16978959 DETECTION OF ALZHEIMER'S DISEASE (AD), FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AMYOTROPHIC LATERAL SCHLEROSIS (ALS), PARKINSON'S DISEASE (PD), AND DEMENTIA WITH LEWY BODIES (DLB) INDICATED BY PHOSPHORYLATION OF MARCKS Non-Final OA DENKA COMPANY LIMITED
18074988 SENSORS FOR ANTIMICROBIAL BIPHASIC POLYMERS, AND SYSTEMS AND METHODS INCORPORATING THE SAME Non-Final OA HRL Laboratories, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month